Sally Susman - Feb 27, 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
/s/ Shanice A. Reid, by power of atty, for Sally Susman
Stock symbol
PFE
Transactions as of
Feb 27, 2025
Transactions value $
$531,162
Form type
4
Date filed
3/3/2025, 05:38 PM
Previous filing
Feb 25, 2025
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $2.67M +85.2K +51.41% $31.31 251K Feb 27, 2025 Direct F1
transaction PFE Common Stock Tax liability -$56.8K -2.18K -0.87% $26.10 249K Feb 27, 2025 Direct F2
transaction PFE Common Stock Tax liability -$2.08M -79.8K -32.08% $26.06 169K Feb 27, 2025 Direct F3, F4
holding PFE Common Stock 866 Feb 27, 2025 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -85.2K -100% $0.00 0 Feb 27, 2025 Common Stock 85.2K $31.31 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.